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Background: The occurrence of Congenital Heart Disease (CHD) is resulted from either genetic or environmental
factors or the both. The CITED2 gene deletion or mutation is associated with the development of cardiac
malformations. In this study, we have investigated the role of CITED2 gene mutation and methylation in the
development of Congenital Heart Disease in pediatric patients in China.
Results: We have screened 120 pediatric patients with congenital heart disease. Among these patients, 4 cases
were detected to carry various CITED2 gene heterozygous mutations (c.550G > A, c.574A > G, c.573-578del6) leading
correspondingly to the alterations of amino acid sequences in Gly184Ser, Ser192Gly, and Ser192fs, respectively. No
CITED2 gene mutations were detected in the control group. At the same time, we found that CITED2 mutations
could inhibit TFAP2c expression. In addition, we have demonstrated that abnormal CITED2 gene methylation was
detected in most of the tested pediatric patients with CHD, which leads to a decrease of CITED2 transcription
activities.
Conclusions: Our study suggests that CITED2 gene mutations and methylation may play an important role in the
development of pediatric congenital heart disease.
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Congenital Heart Disease (CHD) is the most common
disease in children with congenital birth defects, which
is a challenge in pediatric cardiology. A body of studies
has demonstrated that the congenital heart diseases are
caused by either genetic or environmental factors or
both. More and more gene mutations were found to be
associated with CHD, such as NKX2.5, TBX5, TFAP2B,
GATA-4 [1,2]. Although gene mutations are potential
causes for the development of CHD [3], various environ-
mental factors that affect mother during the pregnancy
also play an important role in promoting and developing
of CHD [4]. For example, epigenetic modifications and
gene methylation changes in fetus during pregnancy can
affect gene expression levels during the development
[5-7]. Aberrant methylation in the promoter region of
genes can inhibit gene transcription activities by pre-
venting the binding of transcription factor from the* Correspondence: chongwxy@aliyun.com
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stated.target genes, which is one of the potential causes of gene
silence and disease [8].
CREB-binding protein (CBP)/P300-interacting transac-
tivator 2 is a protein with ED-rich tail that in human is
encoded by the CITED2 gene. CITED2 expression is reg-
ulated by a variety of factors such as hypoxia, cytokines,
oxidative stress, etc. [9]. There are a plurality of tran-
scription factor binding sites in the promoter region of
CITED2 gene, such as HIF-1, AP-2, SP1 etc., which play
a vital role in CITED2 expression. Three consecutive
sequence of "ACGTG" in CITED2 promoter region can
maintain the stability of the combination between
CITED2 and HIF-1 [10,11]. HIF-1 consists of α, β two
subtypes, in which HIF-1α is degraded under normal
oxygen conditions and cannot be detected. However, HIF-
1α can be detected in hypoxic conditions [12]. CITED2
blockes HIF-1α transcriptional activity by competitively
inhibiting the interaction between HIF-1α and CBP/P300,
Dysfunction of HIF-1α in CITED2−/− mice may cause the
cardiac malformation [13,14]. CITED2 also functions as a
transcriptional co-activator by recruiting the combination
of CBP/P300 and TFAP2. Deficiencies in TFAP2 co-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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CITED2-/- mice [15].
CITED2 gene mutation was first reported by Sperling
et al. in congenital heart disease [16] and the mutation
could significantly diminish TFAP2c co-activation. How-
ever, the relationship between CITED2 mutations and
CHD as well as the epigenetic modification of the gene
is not clear. In the present study, we have screened 120
pediatric patients with CHD and tried to reveal the role
of gene mutations and epigenetic modifications in the
development of CHD in children. Our study suggests
that CITED2 gene mutations and methylation may play




Blood samples were obtained from 120 pediatric pa-
tients (from 8 days to 18 years) and from 100 normal
children with matched age. In addition, myocardial tis-
sues were collected from 31 pediatric patients with CHD
in Children's Hospital of Chongqing Medical University
and 2 normal cardiac tissue samples were obtained from
children died of accident (Table 1). The protocols and as-
says of the study was approved by the Ethics Committee
in Children's Hospital Chongqing Medical University be-
fore the start of the study.Table 1 Phenotypies and clinical manifestations of CHD
in pediatric patients
Congenital heart disease n (%) (n = 151)
Right Atrial Isomerism 1 (0.67)
Single Atrium 1 (0.67)
Dextral Heart 2 (1.3)
Aortic Stenosis 2 (1.3)
Aortic Transection 2 (1.3)
Mirror Dextrocardia 2 (1.3)
Atrial Septal Defect with Ventricular Septal Defect 11 (7.28)
Persistent Truncus Arteriosus 3 (2.0)
Complete Transposition of Great Arteries 4 (2.65)
Pulmonary Atresia 4 (2.65)
Total Anomalous Pulmonary Venous Drainage 4 (2.65)
Single Ventricle 5 (3.31)
Pulmonary Stenosis 8 (5.3)
Double Outlet Right Ventricle 10 (6.62)
Atrial Septal Defect 24 (15.9)
Patent Ductus Arteriosus 20 (13.2)
Ventricular Septal Defect 33 (21.9)
Tetralogy of Fallot 13 (8.61)
Complete Atrioventricular Pathways 2 (1.3)Reagents
Blood and Tissue DNA extraction kit was purchased from
Tiangen; plasmid pEGFP-C1 was purchased from Dingguo
biotechnology company; LA Tag enzyme, pMD19-T simple
plasmid restriction enzyme ScaI and KpnI, DNA ligase,
DNA marker, Reverse transcription kits were purchased
from TaKaRa; Endotoxin-free plasmid extraction kit
was purchased from QIAGEN; DMEM medium, fetal bo-
vine serum were purchased from Gibco; Lipofectamine
TM 2000 was purchased from Invitrogen;SsoFastTM
EvaGreen Supermix was purchased from BIO-RAD,
TFAP2c primary antibody, HIF-1α, anti-β-action antibody
were purchased from Bioworld;EZ DNA Methylation-
Gold Kit, methylation positive control and a negative con-
trol were purchased from ZYMO;HepG2 and H9C2 cell
were conserved in our laboratory.
Detection of mutations in CITED2 gene
Blood DNA was extracted from the CHD and healthy
children. CITED2 coding region was cut into S1 and S2
to design primers. The primer sequences used in the as-
says are shown in Table 2. PCR amplification, and then
sequencing were performed. DNA sequence was com-
pared to the normal CITED2 coding sequence in the
Genebank to reveal the mutation sites and types.
Construct CITED2 mutant and wild-type recombinant
plasmid
CITED2 (c.573-578del6) and normal PCR purification
products were connected with pMD19-T simple plasmid.
Then they were transformed into competent E. coli
DH5α and the positive clones were detected. Again, the
positive clones were selected and sequenced.
Transfection of plasmids into the cells
Human hepatoma cell line HepG2 and Rats myocardial
cell lines H9C2 were cultured in DMEM medium con-
taining 10% fetal bovine serum. The medium was chan-
ged regularly. Recombinant plasmids were transfected into
HepG2 and H9C2 using Lipofectamine™ 2000. The trans-
fection efficiency of pEGFP-C1-wtCITED2 and pEGFP-
C1-mtCITED2 were observed by fluorescence microscopy.
The expression of CITED2 was analyzed with Western
blotting. Experimental groups included: Empty vector
group, Untransfected group, Mutation group and Wild-
type control group.
Detection of TFAP2c and HIF-1α mRNA expression by
Q-PCR
After transfection, the cells were cultured in the differ-
ent conditions (21% O2, 74% N2, 5% CO2 at 37°C or 1%
O2, 94% N2, 5% CO2 at 37°C). RNA was extracted after
24 h and reversely transcribed into cDNA. HIF-1α and
TFAP2c was amplified by SsoFast™ EvaGreen Supermix.
Table 2 Specific primers designed for the experiments
Species Gene Primer sequences Amplified length
Human CITED2 S1: Sense: 5'-AGGCTGTTAGTGGGATCTTGG -3' 559 bp
Anti: 5'-CATGTAGTGGTT- GTGGGGGTAG -3'
S2: Sense: 5'-CCAGGTTTAACAACTCCCAGTTC-3'
Anti: 5'-CCACAAGATTAAGCAGTTTGCC-3'
BSP: Sense: 5'-GGTGGGGTAGATTTAGTTTGAGG-3' 350 bp
Anti: 5'-ACTTTAACCACAATTAATATAAACA TTTC -3'




TFAP2c Sense: 5'-AAATCCTTCTCCACCGCACAGACT-3' 100 bp
Anti: 5'-TGATGCAGAACCAGTGAAGGCTCT-3'
HIF-1α Sense: 5'-CGTTCCTTCGATCAGTTGTC-3' 143 bp
Anti: 5'-TCAGTGGTGGCAGTGGTAGT-3'
β-actin Sense: 5'-CATGGGTCAGAAGGATTCCTATGTG-3' 116 bp
Anti: 5'-ATTTTCTCCATGTCGTCCCAGTTG-3'
Rats TFAP2c Sense: 5'-GGATTTAACTGGCGACTAT-3' 79 bp
Anti: 5'-CCTCTTCATACTTGACATTATC-3'
HIF-1α Sense: 5'-CTGCCACCACTGATGAAT-3' 128 bp
Anti: 5'-ACTGTATGCTGATGCCTTAG-3'
β-actin Sense: 5'- TATGGAATCCTGTGGCATC-3' 87 bp
Anti: 5'-GTGTTGGCATAGAGGTCTT-3'
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shown in Table 2. Expression differences of TFAP2c and
HIF-1α mRNA was compared among the four assay
groups. Each experiment was repeated at least three
times.
Detection of TFAP2c and HIF-1α protein levels by
Western blotting
After transfecting, cells were respectively cultured in the
condition of 37°C, 21% O2, 74% N2, 5% CO2 and 37°C,
1% O2, 94% N2, 5% CO2. Proteins were collected after
48 h and boiled with buffer for 5 min and then separated
by SDS-PAGE gel electrophoresis. Transferring protein
onto PVDF and blocking 1 h with 5% skim milk. The
membranes was incubated at 4°C overnight after hatch-
ing TFAP2c and HIF-1α antibodies. The PVDF was
washed three times in PBST. TFAP2c and HIF-1α pro-
tein levels were compared among the four different
groups. At least three independent experiments were
performed.
Detection of methylation in CITED2 gene promoter
region (CpG island)
Genomic DNA was extracted from myocardial tissues of
CHD and control groups and treated with bisulfitemodification using an EZ DNA Methylation-Gold Kit.
This treatment converts unmethylated cytosines to
uracils, while methylated cytosines unchanged. CITED2
(−10 bp ~ −360 bp) region was detected by Bisulfite-PCR
sequencing (BSP). The methylation sites were identified
after PCR amplification of the cloning and sequencing.
The methylation on CITED2 (−971 bp ~ −1171 bp) was
detected using a methylation- specific PCR (MSP) assay.
The methylated or unmethylated samples was analyzed
by 2% agarose gel electrophoresis.
Detection of CITED2 mRNA expression by Q-PCR
RNA was extracted from the methylated and control
groups and reversely transcribed into cDNA. The tran-
scriptional expression of CITED2 gene was detected and
compared. β-actin was used as an internal control.
CITED2: Sense: 5'-TTCCCTCACTTTCTCCAGTGCT
CA-3 antisense: 5'-ATGAAGCGAGATGGCAGTTTGT




Statistical analysis was performed using student's t-test
or Fish's exact test and X2 test. The obtained P values
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SPSS.17.0 software.
Results
Mutations detected in CITED2 coding region
4 heterozygous mutations were detected among 120 pa-
tients with congenital heart disease, Including 2 cases of
point mutations and 2 cases of deletion mutants. These
mutations lead to corresponding amino acid variations
in CITED2 protein. However no mutation were detected
in samples from the 100 normal controls (Table 3).
Measurement of TFAP2c and HIF-1α mRNA expressions
CITED2 wild-type and mutant recombinant plasmids
were constructed successfully. By comparison to the
wild-type plasmid pEGFP-C1-wtCITED2, the recombin-
ant mutant plasmid pEGFP-C1-mtCITED2 could be
identified by the absence of six bases based on sequen-
cing. TFAP2c mRNA expression levels were reduced
significantly in mutant group comparing to the wild-
type group in H9C2 (P < 0.05). The empty vector group
and untransfected group showed no statistical differ-
ence (P > 0.05). By contrast, HIF-1α mRNA expression
levels were higher in the mutant group than that in
wild-type group (P < 0.05) (Figure 1A). Similarly, in
HepG2 cells, we aslo found the same results, TFAP2c
mRNA expression levels were reduced in mutant group
comparing to the wild-type group, But HIF-1α mRNA
expression levels were higher in the mutant group than
that in wild-type group (P < 0.05) ( Figure 1B).
Determination of protein expression levels of TFAP2c
and HIF-1α
The concentrations of TFAP2c protein were reduced in
the mutant group comparing to that of the empty vector
group in H9C2 (P < 0.05). TFAP2c protein concentra-
tions were significantly lower in the mutant group com-
paring to the wild-type control group (P < 0.05). The
empty vector group and untransfected group showed no
significant difference (P > 0.05). Similarly to the mRNA
data, the concentrations of HIF-1α protein was higher in
the mutant group than that of the wild-type control
group (P < 0.05) (Figure 1C). Similarly, in HepG2 cells, ItTable 3 CITED2 gene mutations detected in pediatric
patients with CHD
Nucleotide Amino acid Number Phenotype
c.550G > A p.Gly184Ser 1 Mirror dextrocardia, right aortic
arch, tetralogy of Fallot
c.574A > G p.Ser192Gly 1 Aortic stenosis
c.573-578del6 p.Ser192fs 2 Aortic stenosis and pulmonary
valve stenosis; ventricular
septal defect and atrial septal
defectshows the same results, TFAP2c protein concentrations
were lower in the mutant group comparing to the wild-
type control group (P < 0.05), but the concentrations of
HIF-1α protein was higher in the mutant group than that
of the wild-type control group (P < 0.05) (Figure 1D).
Detection of methylation in CITED2 promoter region
Two methods were used to detect the methylation in
gene promoter region. One was to use bisulfate-PCR
primers (BSP) and the other was to use methylation-
specific PCR primers (MSP). Both primers were de-
scribed in Materials and Methods. The sequencing data
from BSP showed that methylation was detected in 10
cases out of 12 patient samples tested (83% of methyla-
tion positive rate). The samples from the normal con-
trol group were small with only two cases. However,
no methylation was detected in the control samples
(Figure 2A). The MSP showed that the methylation
was detected in 16 cases out of 19 patients with CHD
(84% of methylation-positive rate). No methylation was
detected using this method in 2 normal control sam-
ples (Figure 2B). It was also found that CITED2 ex-
pression levels were significantly decreased in samples
with methylation in CITED2 promoter region com-
pared to that of the samples without methylation in
CITED2 (P < 0.05) (Figure 3).
Discussion
CITED2 gene is one important member of the CITED
family. It is located in chromosome 6q23.3 and contains
three exons and two introns, encoding a protein with
270 amino acids. The amino acid sequence of CITED2
protein is characterized by three conserved regions
(CR1, CR2 and CR3). CR2 is a conserved region consist-
ing of 32 amino acids, which binds with CH1 domain of
CBP/P300. A unique serine-glycine-rich region (SGJ) is
located in its carboxyl terminus. CITED2 gene has about
3 kb of CpG islands in its promoter region and coding
region that may be modified by methylation [10]. In this
study we have detected 4 various mutations in CITED2
coding region (c.550G > A, c.574A > G, c.573-578del6) in
blood samples from pediatric patients with CHD. All of
these mutations are clustered in the SGJ area. The differ-
ent mutations are associated with different phenotypes
of CHD in pediatric patients, and a same mutation
causes different CHD phenotypes. So gene mutation
along can not well explain the occurrence of CHD, sug-
gesting that other factors play roles in the development
of CHD. In this study, we have demonstrated that
methylation levels of certain important genes, such as
CITED2, are associated as well with the development of
the CHD.
Previous studies have shown that CITED2 plays an im-
portant role in the heart development. Lack of CITED2
Figure 1 Expression of TFAP2c, HIF-1α mRNA and protein after the transfection of CITED2 wild-type and mutant recombinant plasmids.
A: Q-PCR analysis showed TFAP2c mRNA expression levels were reduced significantly in mutant group comparing to the wild-type group in
H9C2 (*P < 0.05). By contrast, HIF-1α mRNA expression levels were higher in the mutant group than that in wild- type group (*P < 0.05). B: Q-PCR
analysis showed TFAP2c mRNA expression levels were reduced significantly in mutant group comparing to the wild-type group in HepG2
(*P < 0.05). By contrast, HIF-1α mRNA expression levels were higher in the mutant group than that in wild- type group (*P < 0.05). C: Western-blotting
data demonstrated that TFAP2c protein concentrations were significantly lower in the mutant group comparing to the wild-type control group in
H9C2 (*P < 0.05). But the concentrations of HIF-1α protein was higher in the mutant group than that of the wild-type control group (*P < 0.05).
D: Western-blotting data demonstrated that TFAP2c protein concentrations were significantly lower in the mutant group comparing to the wild-type
control group in HepG2 (*P < 0.05). But the concentrations of HIF-1α protein was higher in the mutant group than that of the wild-type control group
(*P < 0.05).





Figure 2 The clone sequencing and Electrophoresis by BSP and MSP. A. The clone sequencing of reverse complementary chain in CHD and
control group by BSP. a: It shows the methylated sequence in CHD group, arrow represent methylated sites; b: The corresponding non-methylated
sequences in control group, arrow represent unmethylated sites. B. It shows the result of Electrophoresis by MSP. it demonstrates that Methylated strip
exsits in the samples with CHD,but in the control group it shows the Unmethylated strip. It demonstrates that CITED2 methylation exsits in CHD group.
1: DNA Marker 100-600 bp, 2: Blank control (ddH2O), 3: Methylated positive control, 11: Negative control, 4-8: Methylated samples in congenital heart
disease, 9-10: Unmethylated samples in the control group, M: methylated strip, U: unmethylated strip.
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as well as various cardiac malformations including artial
and ventricular septal defects, transposition of great ar-
teries, double outlet right ventricle, tetralogy of fallot
and so on [17]. Heart-specific knockout of CITED2 in
mice leads to a ventricular septal defect and ventricular
wall thinning, as well as abnormal angiogenesis, suggest-
ing that CITED2 plays a vital role in the growth and de-
velopment of ventricular muscles and ventricular septal
coronary vessels [18]. CITED2 can act as a transcription
cofactor assisting various transcription factors to modulatea normal development of the heart. CITED2−/− embryos
can down-regulate Nodal, Lefty2 and Pitx2 expression in
the left side plate mesoderm, which hampers the forma-
tion of the normal axis of the mouse heart [19]. CITED2
and HIF-1α can competitively bind on CH1 domain of
CBP/P300. So CITED2 has been proposed to be a
negative-feedbacked inhibitor under a hypoxic environ-
ment to limit HIF-1α overexpression. This negative feed-
back action is diminished when CITED2 gene is deleted or
downregulated, which leads to an overexpression of HIF-
























Figure 3 Expression of CITED2 mRNA in CITED2 methylated
group and control group. It shows that CITED2 expression levels
were significantly decreased in samples with methylation in CITED2
promoter region compared to that of the samples without methylation
in CITED2 gene (*P < 0.05).
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is diminished by CITED2 mutations detected in pediatric
patients with CHD. As a consequence, the HIF-1α expres-
sion is enhanced in pediatric CHD patients with CITED2
mutations. The overexpression of HIF-1α might bring the
following events that are associated with the development
of CHD: 1) HIF-1α can suppress cell apoptosis in cardiac
outflow tract. Cell apoptosis will be inhibited because of
HIF-1α overexpression, which hinders the development of
cardiac outflow tract. 2) HIF-1α overexpression can in-
crease the expression of its target gene VEGF, which
blocks the development of vasculature and leads to myo-
cardial ischemia and hypoxia. 3) HIF-1α overexpression
inhibits migration and transition of neural crest cell, which
hinders the formation of a normal heart.
The CR3 binding domain of CITED2 can bind with
TFAP2, and its CR2 binding domain can bind CBP/
P300, So CITED2 as a bridge between TFAP2 and CBP/
P300 can activate the transcription activity of TFAP2.
Lower TFAP2 transcriptional activity in CITED2−/−
mice confirmed this view [24]. TFAP2c and TFAP2a can
interact with CITED2, especially TFAP2c [25]. In our
study the connection between TFAP2c and CBP/P300
weaked owing to CITED2 mutation, so there is a reduc-
tion in TFAP2c. Abnomal expression of TFAP2c can
limit the development of cardiac neural rest. TFAP2c
low expression further affect transcriptional regulator
Pitx2 expression, which hamper the formation of the
normal axis of the heart.
Methylation is a process that transfers –CH3 to the
specific base. Gene methylation plays a critical role in
cell proliferation, differentiation and apoptosis. Aberrant
methylation was mainly induced by environmental fac-
tors. And the incidence of congenital heart disease is
closely associated with environmental factors during the
pregnancy. Various factors during the pregnancy, such
as ethanol, riboflavin and folic acid, can induce genemethylations in vivo [26-30]. Studies have shown that
maternal high-fat diet combined with CITED2 gene de-
letion can increase penetrance of the heart abnormality
body axis [31]. A close correlation has been discovered
between congenital heart disease with the CITED2 gene
deletion and environmental alteration. Zhu et al. re-
ported that several abnormally methylated bases were
found in ventricular septal defects and NOX5 hyperme-
thylation in CpG island can inhibit its expression [32].
Our study confirms that methylation of CITED2 gene
promoter region is observed in pediatric patients with
CHD and the methylation can decrease CITED2 tran-
scription activity.Conclusions
In conclusion, our study discovers the CITED2 gene
mutations as well as CITED2 gene promoter region
methylation in pediatric patients with CHD, which affects
transcriptional activity of TFAP2c and HIF-1α. The latter
are closely associated with the heart development. Our
data suggest that both gene mutations and epigenetic
modifications play a role in the development of CHD.Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.
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